David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Commerce Bancshares
CBSH
$8.34B
| $444K | ﹤0.01% |
+8,752
| New | +$409K |
|
3402
Ennis
EBF
$538M
| $443K | ﹤0.01% |
20,440
+4,846
| +31% | +$98.5K |
|
3403
PUT
Harley-Davidson
HOG
$2.89B
| $443K | ﹤0.01% |
11,900
| – | – |
|
3404
VSE Corp
VSEC
$6.13B
| $443K | ﹤0.01% |
11,641
+655
| +6% | +$24.4K |
|
|
CNR
3405
Core Natural Resources Inc
CNR
$4.74B
| $442K | ﹤0.01% |
+30,493
| New | +$421K |
|
3406
Sturm, Ruger & Co
RGR
$610M
| $441K | ﹤0.01% |
9,383
-370
| -4% | -$16.8K |
|
3407
CALL
Best Buy
BBY
$18B
| $439K | ﹤0.01% |
5,000
-64,500
| -93% | -$4.94M |
|
3408
uniQure
QURE
$3.47B
| $438K | ﹤0.01% |
6,119
-20,322
| -77% | -$1.12M |
|
|
SVM
3409
Silvercorp Metals
SVM
$2.82B
| $438K | ﹤0.01% |
77,500
-6,700
| -8% | -$31.2K |
|
|
ALBO
3410
DELISTED
Albireo Pharma Inc
ALBO
| $438K | ﹤0.01% |
+17,237
| New | +$345K |
|
3411
Novanta
NOVT
$5.32B
| $437K | ﹤0.01% |
4,938
-110
| -2% | -$9.49K |
|
3412
Walker & Dunlop
WD
$1.34B
| $437K | ﹤0.01% |
6,759
-2,973
| -31% | -$188K |
|
|
BITA
3413
DELISTED
Bitauto Holdings Limited
BITA
| $435K | ﹤0.01% |
29,299
-8,502
| -22% | -$128K |
|
3414
Preferred Bank
PFBC
$1.23B
| $434K | ﹤0.01% |
7,219
+3,119
| +76% | +$171K |
|
3415
Royal Gold
RGLD
$22.5B
| $434K | ﹤0.01% |
3,549
-8,790
| -71% | -$1.04M |
|
3416
B&G Foods
BGS
$276M
| $433K | ﹤0.01% |
24,139
-609,171
| -96% | -$10.2M |
|
|
DBD
3417
CALL
DELISTED
Diebold Nixdorf Incorporated
DBD
| $433K | ﹤0.01% |
41,000
| – | – |
|
|
QTT
3418
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
| $433K | ﹤0.01% |
+12,712
| New | +$424K |
|
|
MSGN
3419
DELISTED
MSG Networks Inc.
MSGN
| $431K | ﹤0.01% |
24,759
-4,190
| -14% | -$69.7K |
|
3420
Cerence
CRNC
$350M
| $430K | ﹤0.01% |
+19,007
| New | +$312K |
|
|
PLAN
3421
CALL
DELISTED
Anaplan, Inc.
PLAN
| $430K | ﹤0.01% |
8,200
| – | – |
|
|
AXDX
3422
DELISTED
Accelerate Diagnostics
AXDX
| $428K | ﹤0.01% |
+2,535
| New | +$418K |
|
3423
Newell Brands
NWL
$2.55B
| $426K | ﹤0.01% |
22,183
+1,983
| +10% | +$38.2K |
|
3424
Team
TISI
$109M
| $425K | ﹤0.01% |
2,660
-3,645
| -58% | -$617K |
|
|
WTRE
3425
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $425K | ﹤0.01% |
16,882
+9,234
| +121% | +$245K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.